All articles by GlobalData Healthcare

Wegovy portfolio growth shifts to the pill as injectable sales forecast to plateau

In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation of…
US vaccine manufacturers set to lose as RFK pushes for weaker vaccine mandates

Earlier this year, the Trump Administration, backed by US Health and Human Services Secretary Robert F Kennedy (RFK) Jr, a…
Multiple Myeloma Awareness Month: the current and future landscape

March is Multiple Myeloma (MM) Awareness Month, which raises awareness, action, and amplifies the voices of individuals impacted by MM,…
SLE and LN market expected to reach $5.9bn across 7MM by 2034

A notable growth in the systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM;…
Significant opportunities exist in the global pain market for novel mechanisms and modalities

Pain is a multifaceted, highly heterogeneous disorder that is treated using analgesics. There is a lack of diversity within the…

AbbVie’s $100bn deal aligns drug pricing with domestic manufacturing goals

Under the three-year deal, AbbVie agreed to lower prices on certain Medicaid drugs and expand distribution through the TrumpRx direct-to-patient…
The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears

This year, sales of Bristol Myers Squibb’s (BMS) and Pfizer’s drug Eliquis (apixaban) are projected to decline by 15.2% due…
UK–US zero‑tariff deal pricing reforms position UK as global hub for new medicines

The key element of the agreement is confirmation that UK pharmaceutical exports to the US will face a preferential tariff…
JPM26: Immunocore Signals Entry into type 1 diabetes

At the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on 14th January 2026, Immunocore outlined 2026 strategic priorities…
JPM26: Atea Pharmaceuticals outlines HCV strategy centred on short-duration regimens

At the 44th Annual J.P. Morgan Healthcare Conference, Atea Pharmaceuticals outlined its strategy for hepatitis C virus (HCV), showcasing its…

Sections